This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function
D3_CVID_TCELL
obsolete_common variable immunodeficiency: ['A hypogammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells. Patients with common variable immunodeficiency have marked reduction in serum levels of both immunoglobulin G (IgG) and immunoglobulin A (IgA); about half of these patients also have reduced immunoglobulin M (IgM).', 'A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.', 'Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
46 |
4. Check minimum number of eventsNone |
46 |
5. Include endpointsNone |
46 |
6. Filter based on genotype QC (FinnGen only) |
46 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D83
- Name in latin
- Deficientia immunalis variabilis communis praecipue cum abnormalitatibus cellularum T immunoregulatoriarum
Similar endpoints
↥List of similar endpoints to
Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function
based on the number of shared cases.
Similar with more cases:
- Common variable immunodeficiency
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 204 | 98 | 102 |
| Only index persons | 165 | 86 | 79 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 60.05 | 57.52 | 61.99 |
| Only index persons | 57.77 | 56.84 | 58.79 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 46 | 28 | 18 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 61.19 | 56.53 | 68.42 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004789) Transferrin [Mass/volume] in Serum or Plasma
18
57
4.55
5.48
7.0
1.7
g/l
2.1
2.5
1.19
18
50
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
17
53
4.50
5.25
8.1
1.8
%
23.5
21.0
0.29
17
42
(3022948) Iron [Moles/volume] in Serum or Plasma
17
59
3.98
4.48
8.5
1.7
umol/l
12.0
11.7
0.07
17
54
(3018405) Lactate [Moles/volume] in Arterial blood
7
9
8.91
3.70
3.1
3.9
mmol/l
1.3
1.9
—
7
9
(42870588) Differential panel, method unspecified - Blood
24
121
3.06
3.38
23.6
4.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
12
6.65
3.15
1.7
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
119
2.87
3.02
7.0
3.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
20
99
2.80
2.81
6.8
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
19
95
2.70
2.59
7.3
3.2
e6/l
0.4
0.4
0.02
11
68
(3000492) Spirometry study
9
27
3.88
2.55
3.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
12
5.56
2.48
2.7
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
54
2.96
2.46
1.4
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
17
82
2.70
2.46
5.8
2.1
mg/l
2.6
2.7
0.17
17
69
(3022096) Basophils/100 leukocytes in Blood
26
159
2.46
2.27
28.0
5.2
%
0.7
0.7
0.13
26
147
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
9
6.07
2.27
1.4
1.0
g/l
1.2
1.2
—
5
9
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
19
4.15
2.25
14.0
17.6
%
1.0
0.6
—
7
19
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
19
4.15
2.25
14.0
17.6
%
1.6
1.5
—
7
19
(40758558) Short blood count panel - Blood
16
78
2.61
2.24
25.7
7.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
16
78
2.61
2.24
4.7
3.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
26
163
2.37
2.11
28.3
5.1
%
2.5
2.5
0.04
26
151
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
59
2.68
2.08
4.1
2.7
e6/l
1.1
0.9
—
7
29
(3019069) Monocytes/100 leukocytes in Blood
26
164
2.35
2.07
28.8
5.6
%
10.4
8.6
1.98
26
152
(3024561) Albumin [Mass/volume] in Serum or Plasma
25
156
2.32
2.02
10.4
4.9
g/l
32.6
35.6
1.62
25
144
(3021447) Carbon dioxide [Partial pressure] in Venous blood
7
22
3.56
1.97
7.7
3.1
kpa
5.6
6.2
—
7
22
(3002030) Lymphocytes/100 leukocytes in Blood
26
169
2.24
1.87
28.8
5.3
%
25.5
27.3
0.42
26
157
(3027945) Reticulocytes/100 erythrocytes in Blood
9
36
2.86
1.86
2.1
1.9
%
1.9
1.7
—
9
31
(3024354) Oxygen [Partial pressure] in Venous blood
6
18
3.67
1.81
3.8
2.2
kpa
3.5
4.0
—
6
18
(3014007) Fractional oxyhemoglobin in Arterial blood
6
18
3.67
1.81
16.2
18.5
%
92.9
94.6
—
6
18
(3012544) pH of Venous blood
7
24
3.25
1.80
7.7
3.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
5
13
4.17
1.76
9.8
3.7
mmol/l
23.4
24.2
—
5
13
(3007853) Bacteria identified in Skin by Aerobe culture
10
43
2.69
1.74
1.9
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
19
112
2.19
1.70
7.4
3.3
e6/l
11.2
618.1
0.51
12
83
(3007164) IgA [Mass/volume] in Serum or Plasma
14
73
2.32
1.66
5.6
1.4
g/l
1.7
2.7
—
9
39
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
14
3.87
1.66
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
12
59
2.40
1.61
4.3
3.0
e6/l
1.7
2.3
—
6
29
(3018010) Neutrophils/100 leukocytes in Blood
25
167
2.09
1.61
27.4
5.1
%
59.2
57.6
0.30
25
157
(3015736) pH of Urine
22
140
2.10
1.61
6.0
3.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
21
3.13
1.56
2.7
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
6
22
2.98
1.49
4.5
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
19
118
2.04
1.45
3.3
2.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
55
2.31
1.41
3.5
3.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
95
2.05
1.36
3.3
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
20
129
1.97
1.36
9.0
4.1
e6/l
14.2
63.3
1.59
13
86
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
25
318
0.53
1.22
4.6
4.1
mmol/l
1.3
1.2
0.19
20
295
(3000494) Fungus identified in Specimen by Culture
8
41
2.15
1.15
1.5
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
16
101
1.90
1.13
7.8
4.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
21
145
1.82
1.13
9.0
2.6
ug/l
70.7
91.6
0.51
21
134
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
13
77
1.96
1.09
2.1
1.7
mg/l
1.8
0.9
—
8
57
(3036481) Cortisol [Moles/volume] in Serum or Plasma
7
35
2.18
1.05
1.4
1.9
nmol/l
257.3
368.3
—
7
29
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
31
0.00
1.00
0.0
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
32
0.00
0.99
0.0
1.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
31
247
1.78
0.98
8.4
4.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
33
1.94
0.82
1.5
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
23
2.31
0.79
2.2
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
23
2.31
0.79
1.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
5
25
2.12
0.75
26.4
14.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
41
1.83
0.74
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
26
2.03
0.73
3.0
22.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
15
105
1.64
0.72
2.7
2.2
u/l
161.1
186.0
0.17
15
98
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
44
1.69
0.68
2.4
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
63
1.75
0.68
2.2
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
22
0.00
0.61
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
22
0.00
0.61
0.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
36
1.76
0.59
14.3
7.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
14
101
1.56
0.58
1.9
3.1
u/l
53.1
54.6
0.07
14
93
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
45
1.65
0.52
2.4
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
77
1.56
0.51
12.5
4.2
—
—
—
0
0
(3002256) Pathology report gross observation
7
46
1.61
0.51
1.0
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
7
47
1.58
0.50
30.7
26.0
—
1.5
—
0
7
(3022145) Colonoscopy Study observation
7
47
1.58
0.50
1.9
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
33
1.58
0.43
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
33
1.58
0.43
4.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
16
0.00
0.42
0.0
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
35
1.48
0.40
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
17
137
1.38
0.40
3.8
3.8
ng/l
58.0
71.8
0.11
11
93
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
6
44
1.42
0.36
5.7
5.5
ug/l
4.6
107.0
—
6
35
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
45
1.38
0.35
2.0
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
7
95
0.69
0.35
9.1
3.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
35
322
1.36
0.31
32.2
14.4
ml/min/173m2
81.0
79.2
0.18
30
256
(3026493) Urate [Moles/volume] in Serum or Plasma
11
88
1.33
0.25
3.5
2.4
umol/l
316.4
8234.9
0.79
11
70
(3026008) Bacteria identified in Urine by Culture
15
128
1.26
0.22
5.2
2.6
—
—
—
0
0
(4034850)
0
11
0.00
0.21
0.0
13.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
3.0
—
104.4
—
0
11
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
13
0.00
0.21
0.0
1.8
—
2.2
—
0
7
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
0
14
0.00
0.20
0.0
1.4
—
23.9
—
0
14
(3044889) 12 lead EKG panel
22
241
0.83
0.18
4.8
3.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
8
69
1.19
0.18
1.8
1.8
pmol/l
358.6
492.0
—
8
61
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
6
79
0.72
0.17
3.8
5.1
ug/l
2.7
2.1
—
6
65
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20
184
1.15
0.12
4.7
4.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
17
155
1.15
0.11
2.8
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
126
1.16
0.10
7.3
3.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
53
1.15
0.09
1.2
1.8
—
—
—
0
0
(3013512) EKG study
9
99
0.89
0.07
4.6
4.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
19
201
0.91
0.06
3.7
3.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
31
300
1.10
0.05
45.7
17.8
%
39.7
40.3
0.32
21
219
(3003694) ABO and Rh group [Type] in Blood
10
103
0.96
0.00
1.2
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
35
353
0.96
0.00
23.4
14.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
29
286
1.04
0.00
45.3
19.2
%
14.3
13.8
1.07
29
280
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
314.2
—
0
6
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
3.7
—
0
6
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
8
86
0.92
0.00
1.4
1.1
—
1.8
—
0
17
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
8
0.00
0.00
0.0
3.9
—
7.9
—
0
8
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4024509)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
50.0
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
8
0.00
0.00
0.0
3.9
—
5.2
—
0
8
(3028271) Lactate [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
3.2
—
1.7
—
0
6
(3008898) HLA-B27 [Presence]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010421) pH of Blood
0
8
0.00
0.00
0.0
4.0
—
7.4
—
0
8
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
306.2
—
0
6
(3022806) Fractional oxyhemoglobin in Capillary blood
0
5
0.00
0.00
0.0
3.6
—
88.9
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
2.6
—
0
7
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_CVID_TCELL and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have D3_CVID_TCELL.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: D3_CVID_TCELL – Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data